Medical Incubator Japan logo

Medical Incubator Japan

Asia, Tokyo, Japan, Tokyo

Description

Medical Incubator Japan is an investment company.

Investor Profile

Medical Incubator Japan has made 5 investments, with 1 in the past 12 months and 20% as lead.

Stage Focus

  • Series D (20%)
  • Series B (20%)
  • Series C (20%)
  • Series A (20%)
  • Series Unknown (20%)

Country Focus

  • United Kingdom (40%)
  • Japan (20%)
  • United States (20%)
  • Denmark (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Beauty
  • Medical
  • Nursing And Residential Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medical Incubator Japan frequently co-invest with?

UTokyo Innovation Platform
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
CS
North America, Connecticut, United States, Stamford
Co-Investments: 1
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
CareNet
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Keio Innovation Initiative
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Sumitomo Mitsui Trust Investment
Asia, Chiba, Japan, Minato
Co-Investments: 1
Arcus Investment
Europe, England, United Kingdom, London
Co-Investments: 1
KOEI TECMO CAPITAL
Asia, Kanagawa, Japan, Yokohama
Co-Investments: 1
Ci:z Investment
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
NI
Asia, Tokyo, Japan, Konan
Co-Investments: 1

Which angels does Medical Incubator Japan often collaborate with?

RK
North America, California, United States, Los Angeles
Shared Deals: 1
SA
Asia, Hong Kong
Shared Deals: 1
NT
North America, Louisiana, United States
Shared Deals: 1

What are some of recent deals done by Medical Incubator Japan?

ILC Therapeutics

Newhouse, North Lanarkshire, United Kingdom

ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.

BiotechnologyHealth CareLife Science
Series UnknownSep 11, 2024
Amount Raised: $3,259,537
Hoba Therapeutics

Copenhagen, Hovedstaden, Denmark

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

BiotechnologyHealth CarePharmaceutical
Series ADec 10, 2023
Amount Raised: $24,760,070
Heartseed

Tokyo, Tokyo, Japan

Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine”.

BeautyBiotechnologyHealth CareMedicalNursing and Residential Care
Series DMay 25, 2023
Amount Raised: $14,283,147
Blueberry Therapeutics

Alderley Edge, Cheshire, United Kingdom

Blueberry Therapeutics focuses on developing medicines for inflammatory and infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series BFeb 16, 2021
Amount Raised: $4,998,743
DiscGenics

Salt Lake City, Utah, United States

Regenerative Cell Therapy for Chronic Back Pain.

BiotechnologyHealth CareLife ScienceTherapeutics
Series CAug 25, 2020
Amount Raised: $50,000,000